The VEITHsymposium (Vs) grew out of a small meeting started in the early 1970s by Henry Haimovici. The early meetings, which were held in the Roosevelt Hotel in New York City, were sponsored by Montefiore Medical Center. The meeting had a 2-page program, 10-15 Faculty members and attracted less than 100 attendees. After the first three meetings, Frank J. Veith succeeded Dr. Haimovici as Chief of Vascular Surgery at Montefiore and Albert Einstein College of Medicine and became the Chairman of the meeting. Over the next 4 decades, as vascular surgery grew and matured as a specialty, the meeting has grown in size, scope and international flavor. It now attracts about 5, 00 attendees, has about 600 faculty members and its program fills 128 pages.
The meeting’s growth, importance and success are based on several factors and some good luck. The most important has been the emergence of vascular surgery as a specialty and the evolution of a myriad of new developments in and treatments for non-cardiac vascular disease. These treatments have included dramatic improvements in medical treatment, the transformative introduction of endovascular treatments including endografts as well as a plethora of new, effective operative techniques. This explosive growth of vascular treatments mandates that all vascular specialists commit to non-cardiac vascular disease as an area of interest and stay up-to-date with current advances in that area. This in turn can only be accomplished by attendance at balanced, unbiased CME meetings such as the VEITHsymposium. There is no substitute for such meetings. Textbooks and journals help, but can never be as balanced and up-todate as our meeting. Moreover, the interaction with other attendees, faculty and industry representatives is an invaluable way for vascular surgeons and other vascular specialists to keep up with current developments that allow them to treat their patients optimally. Such interactions along with presentations of all the key latest developments happen at our meeting.